/PRNewswire/ BIOCAPTIVA Ltd ("BIOCAPTIVA"), a company developing the BioCaptis – a revolutionary cell-free DNA (cfDNA) capture device designed to transform.
A University of Edinburgh spin-out that says it is pioneering technology to “transform” liquid biopsy testing in cancer-management has announced an oversubscribed £2.1 million additional seed funding round led by Archangels.
Deal financing led by existing investor, Archangels, with participation from Scottish Enterprise, Cancer Research Horizons and new investor Old College Capital, the University of Edinburgh's
Why are you making commenting on The National only available to subscribers? We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions. What should we do with our second vote in 2021? What happens if Westminster says no to indyref2? Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversation, register under fake names, and post vile abuse. We’ve had hundreds of emails from you complaining about this, asking us to take steps to ensure that these people aren’t given a platform on our site.